Omri Bodenheimer

Jerusalem, JM, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Measuring vaccine protection when the population is mostly vaccinated.

Measuring vaccine protection when the population is mostly vaccinated.

Journal: Journal of clinical epidemiology

Published: June 06, 2023

Three phases of increasing complexity in estimating vaccine protection.

Three phases of increasing complexity in estimating vaccine protection.

Journal: International journal of epidemiology

Published: November 15, 2022

Protection against Omicron BA.1/BA.2 severe disease 0-7 months after BNT162b2 booster.

Protection against Omicron BA.1/BA.2 severe disease 0-7 months after BNT162b2 booster.

Journal: Communications biology

Published: September 22, 2022

Association of BNT162b2 Vaccine Third Dose Receipt With Incidence of SARS-CoV-2 Infection, COVID-19-Related Hospitalization, and Death Among Residents of Long-term Care Facilities, August to October 2021.

Association of BNT162b2 Vaccine Third Dose Receipt With Incidence of SARS-CoV-2 Infection, COVID-19-Related Hospitalization, and Death Among Residents of Long-term Care Facilities, August to October 2021.

Journal: JAMA network open

Published: July 07, 2022

Association of Receipt of the Fourth BNT162b2 Dose With Omicron Infection and COVID-19 Hospitalizations Among Residents of Long-term Care Facilities.

Association of Receipt of the Fourth BNT162b2 Dose With Omicron Infection and COVID-19 Hospitalizations Among Residents of Long-term Care Facilities.

Journal: JAMA internal medicine

Published: June 23, 2022

Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2.

Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2.

Journal: The New England journal of medicine

Published: May 25, 2022

Initial protection against SARS-CoV-2 omicron lineage infection in children and adolescents by BNT162b2 in Israel: an observational study.

Initial protection against SARS-CoV-2 omicron lineage infection in children and adolescents by BNT162b2 in Israel: an observational study.

Journal: The Lancet. Infectious diseases

Published: May 22, 2022

Protection by a Fourth Dose of BNT162b2 against Omicron in Israel.

Protection by a Fourth Dose of BNT162b2 against Omicron in Israel.

Journal: The New England journal of medicine

Published: April 05, 2022

Protection following BNT162b2 booster in adolescents substantially exceeds that of a fresh 2-dose vaccine.

Protection following BNT162b2 booster in adolescents substantially exceeds that of a fresh 2-dose vaccine.

Journal: Nature communications

Published: January 13, 2022

Effects of BNT162b2 Covid-19 Vaccine Booster in Long-Term Care Facilities in Israel.

Effects of BNT162b2 Covid-19 Vaccine Booster in Long-Term Care Facilities in Israel.

Journal: The New England journal of medicine

Published: December 22, 2021

Protection against Covid-19 by BNT162b2 Booster across Age Groups.

Protection against Covid-19 by BNT162b2 Booster across Age Groups.

Journal: The New England journal of medicine

Published: December 08, 2021

Waning Immunity after the BNT162b2 Vaccine in Israel.

Waning Immunity after the BNT162b2 Vaccine in Israel.

Journal: The New England journal of medicine

Published: October 27, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026